24/7 Wall St.1d agoneutral
Gilead Pays a $3.28 Annual Dividend Despite Negative Earnings. Is It Safe?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.3d agobullish
Did Earnings Beat Just Shift Gilead Sciences' (GILD) Investment Narrative?Investor's Business Daily9d agoneutral
How Gilead, Which Just Hit A Record, Notched Its Best Sales Growth In A DecadeMT Newswires9d agobullish
UBS Adjusts Gilead Sciences Price Target to $195 From $175, Maintains Buy RatingSimply Wall St.41d agoneutral
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend?Pharmaceutical Technology60d agoneutral
Gilead launches research facility in US for new medicine developmentInsider Monkey77d agoneutral
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?